home

Controls & Specialty Plasmas
Reagents
Diagnostic Kits
Customized Solutions

News & Events

February 12, 2018

Precision BioLogic is pleased to announce the publication of data from a recent research study conducted in conjunction with Sobi, an international specialty healthcare company dedicated to rare diseases, to assess agreement between European haemostasis laboratories in measuring FIX activity in plasma samples containing various levels of rFIXFc (Alprolix®). Findings will help laboratories to be aware of their level of variability and address it to allow for proper patient treatment.

On The Fritsma Factor

February 19, 2018

From Dave McGlasson, does anyone have a reference on why a geometric mean is used in the INR...